Mydecine Innovations Group Inc. announced that it has entered into a subscription agreement for private placement of 326,666 common shares at a price of CAD 0.75 per share for gross proceeds of CAD 244,999.50 with a third-party investor on August 15, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0112 USD | +112.04% | 0.00% | -24.83% |
05-01 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
02-23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
-24.83% | 694K | |
+23.83% | 44.96B | |
+0.30% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.67% | 26.08B | |
-21.15% | 19.03B | |
+6.76% | 12.75B | |
+29.23% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. announced that it expects to receive CAD 0.245 million in funding